Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -33.87% is 18% above its 5-year average of -41.21%, near the high end of its 5-year range (-51.32%–-26.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.22% above its 12-month average of -45.90%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -33.87%.
RETURN ON INVESTED CAPITAL (ROIC)
-33.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-45.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-46.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-41.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+26.22%
CURRENT VS 3Y AVG
+26.71%
CURRENT VS 5Y AVG
+17.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+4.99%
vs the sector median at left
Relay Therapeutics, Inc.
Market Cap
$4.02B
Return on Invested Capital (ROIC)
-33.87%
TTM Avg
-45.90%
3Y Avg
-46.21%
5Y Avg
-41.21%
Market Cap
$4.05B
Return on Invested Capital (ROIC)
-17.95%
TTM Avg
-20.66%
3Y Avg
-12.14%
5Y Avg
-3.93%
Market Cap
$3.97B
Return on Invested Capital (ROIC)
3.11%
TTM Avg
1.40%
3Y Avg
0.58%
5Y Avg
2.33%
Market Cap
$4.14B
Return on Invested Capital (ROIC)
10.24%
TTM Avg
7.56%
3Y Avg
2.02%
5Y Avg
-0.82%
Market Cap
$3.85B
Return on Invested Capital (ROIC)
-69.75%
TTM Avg
-63.60%
3Y Avg
-55.78%
5Y Avg
-83.39%
Market Cap
$4.29B
Return on Invested Capital (ROIC)
-48.57%
TTM Avg
-35.38%
3Y Avg
-31.64%
5Y Avg
-25.98%
Market Cap
$4.40B
Return on Invested Capital (ROIC)
-6.67%
TTM Avg
-24.96%
3Y Avg
-29.08%
5Y Avg
-26.21%
Market Cap
$4.44B
Return on Invested Capital (ROIC)
-23.69%
TTM Avg
-46.07%
3Y Avg
-46.68%
5Y Avg
-46.68%
Market Cap
$4.43B
Return on Invested Capital (ROIC)
N/A
TTM Avg
37.59%
3Y Avg
8.11%
5Y Avg
6.10%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | $4.02B | -33.87% | -45.90% | -46.21% | -41.21% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.05B | -17.95% | -20.66% | -12.14% | -3.93% |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 3.11% | 1.40% | 0.58% | 2.33% |
| LivaNova PLC (LIVN)vs › | $4.14B | 10.24% | 7.56% | 2.02% | -0.82% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.85B | -69.75% | -63.60% | -55.78% | -83.39% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.29B | -48.57% | -35.38% | -31.64% | -25.98% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.40B | -6.67% | -24.96% | -29.08% | -26.21% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.44B | -23.69% | -46.07% | -46.68% | -46.68% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | N/A | 37.59% | 8.11% | 6.10% |
| Veracyte, Inc. (VCYT)vs › | $3.57B | 6.72% | 3.30% | -1.32% | -3.44% |
ROIC
-33.9%
ROE
-32.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -33.87% |
| 2026-03-31 | -44.26% |
| 2025-12-31 | -50.82% |
| 2025-09-30 | -51.32% |
| 2025-06-30 | -49.27% |
| 2025-03-31 | -48.14% |
| 2024-12-31 | -45.39% |
| 2024-09-30 | -42.99% |
| 2024-06-30 | -49.06% |
| 2024-03-31 | -45.03% |
| 2023-12-31 | -45.84% |
| 2023-09-30 | -41.30% |
| 2023-06-30 | -41.10% |
| 2023-03-31 | -34.92% |
| 2022-12-31 | -28.89% |
| 2022-09-30 | -26.81% |
| 2022-06-30 | -31.84% |
| 2022-03-31 | -42.39% |
| 2021-12-31 | -37.06% |
| 2021-09-30 | -40.74% |
| 2021-06-30 | -34.48% |
| 2021-03-31 | -9.50% |
| 2020-12-31 | -7.10% |
| 2020-09-30 | -15.84% |
| 2020-06-30 | -30.40% |
| 2020-03-31 | -26.23% |
| 2019-12-31 | -22.06% |
